ব্যবসার জন্য পাইকারি দামে পণ্য কিনতে রেজিস্টেশন করুন

0 People recently viewed this

Ticstop 12.5

Name: Ticstop 12.5 12.5mg Tablet
Brand: Square Pharmaceuticals PLC.
SKU: 44291
Price: 180 BDT
Availability: InStock
Rating: 4.9 (5 reviews)

Tablet - (12.5mg)

Square Pharmaceuticals PLC.

Generic: Tetrabenazine

Safety Advices

বাংলা

English

UNSAFE

Ticstop 12.5 may cause excessive drowsiness with alcohol.

CONSULT YOUR DOCTOR

Ticstop 12.5 may be unsafe to use during pregnancy. Although there are limited studies in humans, animal studies have shown harmful effects on the developing baby. Your doctor will weigh the benefits and any potential risks before prescribing it to you. Please consult your doctor.

CONSULT YOUR DOCTOR

Ticstop 12.5 is probably unsafe to use during breastfeeding. Limited human data suggests that the drug may pass into the breastmilk and harm the baby.

UNSAFE

Ticstop 12.5 may decrease alertness, affect your vision or make you feel sleepy and dizzy. Do not drive if these symptoms occur.

CONSULT YOUR DOCTOR

There is limited information available on the use of Ticstop 12.5 in patients with kidney disease. Please consult your doctor. However, caution is advised in these patients.

UNSAFE

Ticstop 12.5 is probably unsafe to use in patients with liver disease and should be avoided. Please consult your doctor.

Medicine Overview of Ticstop 12.5 12.5mg Tablet

Introduction

Ticstop 12.5 is a prescription medicine used to treat Huntington's disease, a condition in which nerve cells in the brain breakdown over time, thus deteriorating the person’s physical and mental abilities. It also helps to relieve uncontrollable and jerky movements of the body. Ticstop 12.5 should be taken with or without food. However, it is advised to take it at the same time each day as this helps to maintain a consistent level of medicine in the body. Take this in the dose and duration as advised by your doctor and if you have missed a dose, take it as...

... Show more

Uses of Ticstop 12.5

Huntington's disease

Side effects of Ticstop 12.5

Common

Nausea
Insomnia (difficulty in sleeping)
Anxiety
Fatigue
Sleepiness
Akathisia (inability to stay still)
Depression

How to use Ticstop 12.5

Take this medicine in the dose and duration as advised by your doctor. Swallow it as a whole. Do not chew, crush or break it. Ticstop 12.5 may be taken with or without food, but it is better to take it at a fixed time.

How Ticstop 12.5 works

Ticstop 12.5 works by depleting the stores of certain chemical messengers in the brain that helps in controlling body movements.

Quick Tips

You have been prescribed Ticstop 12.5 to help control movement disorders such as in Huntington’s disease.

Be cautious while driving or doing anything that requires concentration as Ticstop 12.5 can cause dizziness and sleepiness.

Inform your doctor if you experience symptoms such as high fever, sweating, muscle stiffness, and faster breathing. These may be due to a rare side effect known as the neuroleptic malignant syndrome.

Inform your doctor if you develop any unusual changes in mood or behavior, new or worsening depression, or suicidal thoughts or behavior.

Do not stop taking Ticstop 12.5 without talking to your doctor first as it may cause worsening of symptoms.

Brief Description

Indication

Movement disorders, Moderate to severe tardive dyskinesia

Administration

May be taken with or without food.

Adult Dose

Oral Huntington Disease Indicated for treatment of chorea associated with Huntington’s disease Adult: Individualize and slowly titrate dosage over several weeks to identify a dose that reduces chorea and is well tolerated Total daily dose up to 50 mg/day 12.5 mg PO qDay initially; after 1 week, the dose should be increased to 12.5 mg q12hr Maintenance: Titrate slowly by weekly intervals of 12.5 mg/day to identify dose that reduces chorea and is tolerated If daily dose is 37.5 to 50 mg/day, administer in divided doses q8hr Elderly: Initially 12.5 mg daily, increased gradually. Total Daily dose >50 mg/day If...

... Show more

Child Dose

Safety and efficacy not established

Contraindication

Hypersensitivity. Lactation. Hepatic impairment. Patients who are actively suicidal, or who have untreated or inadequately treated depression.

Mode of Action

Reversibly inhibits human vesicular monoamine transporter type 2 (VMAT2), resulting in decreased uptake of monoamines (eg, dopamine, serotonin, norepinephrine, histamine) into synaptic vesicles and depletion of monoamine stores from nerve terminals This effect is similar to reserpine, but with less peripheral activity and is shorter-acting

Precaution

May exacerbate symptoms of parkinsonism. Caution to be exercised when driving or performing skilled tasks. Pregnancy. Increased risk of depression and suicidal thoughts and behavior (suicidality) in patients with Huntington’s disease. Monitor for emergence or worsening of depression, suicidality, or unusual changes in behavior. Caution in patients with a history of depression or prior suicide attempts or ideation.

Side Effect

>10% Sedation/somnolence (31%),Fatigue (22%),Insomnia (22%),Depression (19%),Akathisia (19%),Extrapyramidal event (15%),Anxiety (15%),Nausea (13%) 1-10% Irritability (9%),Bruising (6%),Vomiting (6%),Decreased appetite (4%),Dysuria (4%),Obsessive reaction (4%),Imbalance (9%),Parkinsonism/bradykinesia (9%),Dizziness (4%),Dysarthria (4%),Unsteady gait (4%),Headache (4%) Frequency Not Defined QTc prolongation,Neuroleptic malignant syndrome,Orthostatic Hypotension,Restlessness and agitation,Dysphagia,Depression and suicidality Potentially Fatal: Neuroleptic malignant syndrome (NMS).

Pregnancy Category Note

Pregnancy There are no adequate data on the developmental risk associated with therapy in pregnant women; administration of tetrabenazine to rats throughout pregnancy and lactation resulted in an increase in stillbirths and postnatal offspring mortality Lactation There are no data on presence of tetrabenazine or metabolites in human milk, effects on breastfed infant, or on milk production; developmental and health benefits of breastfeeding should be considered along with mother’s clinical need for therapy and potential adverse effects on breastfed infant or underlying maternal condition

Interaction

Tetrabenazine should not be given with or within 14 days of discontinuation of MAOI therapy. Blocks action of reserpine. Decreases effects of levodopa and worsen parkinsonism. Increased risk of extrapyramidal side effects when given with amantadine, metoclopramide, antipsychotics.

ব্যবসার জন্য পাইকারি দামে পণ্য কিনতে রেজিস্টেশন করুন

0 People recently viewed this

Ticstop 12.5

Tablet - (12.5mg)

Square Pharmaceuticals PLC.

Generic: Tetrabenazine

Additional Offers

Cashback

৳100

For purchasing above ৳5000+

Cashback

৳80

For purchasing above ৳4000+

Cashback

৳60

For purchasing above ৳3000+

Cashback

৳40

For purchasing above ৳2000+

Cashback

৳20

For purchasing above ৳1000+

More from Square Pharmaceuticals PLC.

see all

Frequently Bought Together

Disclaimer

The information provided herein is accurate, updated and complete as per the best practices of the Company. Please note that this information should not be treated as a replacement for physical medical consultation or advice. We do not guarantee the accuracy and the completeness of the information so provided. The absence of any information and/or warning to any drug shall not be considered and assumed as an implied assurance of the Company. We do not take any responsibility for the consequences arising out of the aforementioned information and strongly recommend you for a physical consultation in case of any queries or doubts.

Ticstop 12.5

Medicine Overview of Ticstop 12.5 12.5mg Tablet

Ticstop 12.5

You May Also Like

More from Square Pharmaceuticals PLC.

Frequently Bought Together

Alternative Brands For Ticstop 12.5